News JanOne Inc.

Equities

JAN

US47089W1045

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
4.32 ^USD	+4.60%		+19.01%	+678.38%

18/04	JanOne Files Prospectus for $100 Million Mixed Shelf Offering	MT
15/04	North American Morning Briefing : Stock Futures -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JanOne Files Prospectus for $100 Million Mixed Shelf Offering	18/04	MT
North American Morning Briefing : Stock Futures -2-	15/04	DJ
JanOne Inc. Reports Earnings Results for the Full Year Ended December 30, 2023	09/04	CI
JanOne Regains Compliance with Nasdaq's Listing Requirements	15/03	PR
JanOne Inc. announced that it expects to receive $0.6 million in funding	23/02	CI
JanOne Inc. announced that it expects to receive $0.3 million in funding from Live Ventures Incorporated	07/02	CI
JanOne Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech	09/11	MT
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	09/11	MT
Top Premarket Gainers	09/11	MT
JanOne to Present at the Dawson James 8th Annual Investment Conference	21/23/21	PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference	31/23/31	PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain	29/23/29	PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	28/23/28	AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	26/23/26	PR
JanOne Raises $790,000 in Registered Direct Offering of Shares, Private Placement of Warrants	23/23/23	MT
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules	23/23/23	PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting	21/23/21	AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules	21/23/21	AQ
JanOne Prices Registered Direct Offering, Announces Concurrent Private Placement	21/23/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News JanOne Inc.

Equities

JAN

US47089W1045

Summary

Filters